Webinar: Myocardial Injury in the Era of High-Sensitivity Troponins

cardiac assays
Webinar: Myocardial Injury in the Era of High-Sensitivity Troponins
 
Register Here

Webinar Details:

Date: 9 September 2020
Time: 2.30 pm Malaysia/Singapore time
Location: Microsoft Teams Live

For a smoother webinar experience, please click on the link below to download the Microsoft Teams application to your computer or device that you will be using for this session.

Download Microsoft Teams

Overview

This webinar is organized in collaboration with the Malaysian Association of Clinical Biochemists (MACB) in an effort to advance online education for medical professionals even during these unprecedented times.

Register for this webinar by 7 September 2020!

 

Learn more about cardiac high-sensitivity troponins

  • Cardiac troponins are markers of myocardial necrosis and due to their high cardiac-specificity, are the preferred biomarker for the diagnosis of myocardial infarction.
  • The evolution from relatively insensitive cardiac troponin assays to high-sensitivity assays enables detections of lower levels of troponins and thus, has necessitated evolving testing approaches to optimize clinical utility.
  • The latest generation of high-sensitivity cardiac troponins support rapid diagnostic protocols aiding in the earlier discharge of a significant percentage of non-AMI patients, as well as aid a faster admission.
  • The sensitivity and precision offered by high-sensitivity assays is essential for rapid protocols in order to more accurately differentiate clinically significant change from assay imprecision.

Join us to review the latest updates in the guidelines related to high-sensitivity troponins and their clinical utility within Asia Pacific.

Speaker

Dr Pearline Teo Clinical Marketing Manager, Laboratory Diagnostics, Siemens Healthineers

Dr Pearline Teo received her training in Biology and Immunology from Johns Hopkins University and Stanford University. Since then, she has had more than 10 years of basic, applied and clinical R&D experience in academia and industry, working with various types of products in the medical device and IVD space. Dr Teo has been awarded 2 US patents, and her peer reviewed publications have more than 3500 citations. At Siemens Healthineers, Dr Teo is responsible for clinical education, clinical trials and scientific communications.

Webinar Recording

Register Here

Thank you to everyone who joined us for the webinar. If you have any questions, kindly direct them to us here.